Michael Henrickson

Summary

Affiliation: Children's Hospital Central California
Country: USA

Publications

  1. ncbi Prolonged efficacy of etanercept in refractory enthesitis-related arthritis
    Michael Henrickson
    Division of Rheumatology, Children s Hospital Central California, Madera, California 93638 8762, USA
    J Rheumatol 31:2055-61. 2004
  2. ncbi Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis
    Yukiko Kimura
    Joseph M Sanzari Children s Hospital at Hackensack University Medical Center, Hackensack, New Jersey 07601, USA
    J Rheumatol 32:935-42. 2005
  3. ncbi A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
    Nicolino Ruperto
    IRCCS, Istituto G Gaslini, Genoa, Italy
    Arthritis Rheum 56:3096-106. 2007

Detail Information

Publications3

  1. ncbi Prolonged efficacy of etanercept in refractory enthesitis-related arthritis
    Michael Henrickson
    Division of Rheumatology, Children s Hospital Central California, Madera, California 93638 8762, USA
    J Rheumatol 31:2055-61. 2004
    ..We investigated the longterm efficacy of the TNF fusion protein etanercept in the treatment of patients with ERA refractory to disease modifying antirheumatic drug (DMARD) therapy...
  2. ncbi Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis
    Yukiko Kimura
    Joseph M Sanzari Children s Hospital at Hackensack University Medical Center, Hackensack, New Jersey 07601, USA
    J Rheumatol 32:935-42. 2005
    ..To assess the efficacy and safety of etanercept in a large cohort of children with refractory systemic onset juvenile rheumatoid arthritis (SOJRA)...
  3. ncbi A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
    Nicolino Ruperto
    IRCCS, Istituto G Gaslini, Genoa, Italy
    Arthritis Rheum 56:3096-106. 2007
    ..To evaluate the safety and efficacy of infliximab in the treatment of juvenile rheumatoid arthritis (JRA)...